Read this company snapshot
Daily valuation snapshot
Cencora, Inc.: source evidence dated 2026-10-09.
- Daily close (USD)
- $323.85
- Market capitalization (USD)
- $61,799,377,385.25
- Price / earnings (TTM)
- 23.54
- Price / book
- Not reported
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research COR in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research COR in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing COR with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $323.85 |
| Market capitalization (USD) | $61,799,377,385.25 |
| Price / earnings (TTM) | 23.54 |
| Price / book | Not reported |
No matching rows. Clear the filter to see all records.
Read COR's valuation metrics
Company size
Cencora, Inc.'s recorded market capitalization is $61,799,377,385.25. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
COR's recorded P/E is 23.54: about $23.54 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.
Price relative to book equity
Price-to-book compares market equity value with recorded book equity. Intangible assets, profitability and the company's business affect how useful the comparison is.
Research Cencora, Inc. with Aurora
Use the snapshot above to ask a specific question about COR. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow COR's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.